Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Vestn Oftalmol ; 137(6): 119-127, 2021.
Artigo em Russo | MEDLINE | ID: mdl-34965077

RESUMO

Iontophoresis in medicine is a combined pharmacological and physical method of treatment that unites the therapeutic effect of an electric current with the pharmacological effect of medicinal substances administered at the same time via an electric current. The article describes the physical basis of the therapeutic effect of direct electric current on biological tissues, and highlights the physical and chemical mechanisms of target administration of pharmaceutical substances into the human body through intact skin or mucous membrane by means of direct electric current. In addition, it presents the results of international as well as Russian domestic scientific studies on the clinical effectiveness of iontophoresis in ophthalmology.


Assuntos
Olho , Iontoforese , Humanos , Federação Russa
3.
Vestn Oftalmol ; 137(5. Vyp. 2): 262-267, 2021.
Artigo em Russo | MEDLINE | ID: mdl-34669336

RESUMO

The non-exudative form of age-related macular degeneration (AMD) is a disease with long-term progression for which effective treatments have not been found. Many studies are being conducted to find effective drugs to prevent the appearance of drusen and increase in RPE atrophy area, which could help avoid this more dangerous form of AMD. The main drugs (nutraceuticals) that are used to treat the dry form of AMD are lutein, zeaxanthin and omega-3 fatty acids. Additionally, treatment may include nanosecond laser therapy for drusen in advanced AMD, panretinal subthreshold micropulse laser exposure for atrophic AMD, as well as microcurrent stimulation. Further research in this area should be aimed at understanding all the pathogenetic mechanisms associated with the development of AMD, and developing new approaches to the treatment of this disease including physiotherapy.


Assuntos
Atrofia Geográfica , Degeneração Macular , Drusas Retinianas , Progressão da Doença , Humanos , Luteína , Degeneração Macular/terapia , Zeaxantinas
4.
Vestn Oftalmol ; 137(5. Vyp. 2): 340-345, 2021.
Artigo em Russo | MEDLINE | ID: mdl-34669346

RESUMO

Optic nerve atrophy (ONA) is one of the most common causes of blindness and low vision in the world. The disease occurs in 60-68% of cases. The causes of optic nerve atrophy are diverse: inflammatory and vascular diseases of the optic nerve and retina, glaucoma, atherosclerosis of the main vessels of head and neck, diseases of central nervous system, intoxication of various etiologies, as well as congenital and hereditary diseases. The literature review presents data on the diagnosis and classification of optic nerve atrophy, as well as on drug and non-drug treatment in combination with physiotherapy.


Assuntos
Glaucoma , Atrofia Óptica , Baixa Visão , Atrofia , Cegueira , Humanos , Atrofia Óptica/diagnóstico , Atrofia Óptica/etiologia , Atrofia Óptica/terapia , Nervo Óptico/diagnóstico por imagem , Nervo Óptico/patologia
5.
Med Tr Prom Ekol ; (2): 6-11, 2016.
Artigo em Russo | MEDLINE | ID: mdl-27164744

RESUMO

The article covers treatment results of 90 patients with primary glaucoma simplex of stage 1 and 2 (137 eyes). The authors proved that using a specified magnetotherapy method, when compared to regular medical therapy, causes more fast and marked regression in clinical symptoms and improvement of vision in patients with primary glaucoma simplex of stages 1 and 2.


Assuntos
Cromoterapia/métodos , Glaucoma de Ângulo Aberto/terapia , Oftalmologia/métodos , Estimulação Magnética Transcraniana/métodos , Idoso , Terapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA